BIVI
BIVI
NASDAQ · Biotechnology

Biovie Inc

$1.94
+0.00 (+0.00%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,404.1% upside
Low Target $17.82
Average Target $29.18
High Target $40.31
Current Price $1.94
Current
$1.94
Target
$29.18
$17.82 $29.18 avg $40.31
Scenario Analysis
Bear Case
$17.82
818.6%
Low target
Base Case
$29.18
+1,404.1%
Avg target
Bull Case
$40.31
+1,977.8%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$11.10
-82.5% from high
52-Week Low
$1.06
+83.0% from low
Target vs 52W High
$29.18
+162.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%